What was a commonly known secret finally became official Wednesday when the Utah Hockey Club unveiled its new nickname, the Mammoth, and its logo. Last week, the Utah Mammoth name was shown on the ...

These preclinical candidates integrate the PRO-XTEN™ masking technology with novel TCEs discovered and engineered using Vir Biotechnology’s antibody discovery platform and the Company’s ...

1.1a Congress must establish a National Biotechnology Coordination Office (NBCO) within the Executive Office of the President with a director, appointed by the President, who would coordinate ...

PI, a global leader in precision motion control and nanopositioning, announces fast delivery of its nanometer-precise, high-speed V-308 vertical nanopositioning stage. The system offers 7 mm of ...

Suddenly, the type appears as the cola company’s script logo. The approach emphasizes Coke’s legacy and plays on nostalgia in an analog medium and in an analog way. While so much of soda ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street ...

Get Instant Summarized Text (Gist) A high-density CRISPR interference screening using nearly 33,000 guide RNAs in photosynthetic bacteria identified key genes whose partial suppression enhances ...

The market turbulence unleashed by President Donald Trump’s tariff policies will likely evaporate the trickle of biotech IPOs that were expected in 2025, a capital markets expert has told Fierce.

years of experience at a multinational biotech in Cambridge, and a stint at a biotech startup in the Boston suburbs.

The iconic Texas Longhorns logo — a symbol deeply embedded in tradition — is stirring fresh debate online after a social media influencer unveiled a modern redesign of the classic “Horns ...

Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors.

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...